Home AccuGenomics

AccuGenomics

In operation
-
Biotechnology Developer
Basic
Enterprise Profile

Basic Information

AccuGenomics Develops Unique Spike Control Technology to Enhance Accuracy and Performance of Clinical Sequencing Tests. AccuGenomics is Committed to Improving the Accuracy and Performance of Clinical Sequencing for Better Patient Outcomes. Innovations in NGS Diagnostics are Pushing the Limits of Detection for Low-Abundance Biomarkers, Increasing the Need to Demonstrate the Analytical Performance of These Tests to Patients and Healthcare Providers. AccuGenomics is Actively Developing Technical Solutions to Enable Test Developers and Implementers to Showcase the Highest Levels of Performance of Their Assays.
AccuGenomics, Inc.
Wilmington,Delaware,United States of America
less than 15 people
January 01, 2010
info@accugenomics.com

Enterprise Profile

Industrial Sector
Clinical Trial Institution
Technology
Biotechnology
Concept
Disease Diagnosis